Published in J Neurogenet on April 10, 2014
Losing the sugar coating: Potential impact of perineuronal net abnormalities on interneurons in schizophrenia. Schizophr Res (2015) 1.00
De novo mutations from sporadic schizophrenia cases highlight important signaling genes in an independent sample. Schizophr Res (2015) 0.93
Perineuronal nets and schizophrenia: the importance of neuronal coatings. Neurosci Biobehav Rev (2014) 0.90
Reduced Labeling of Parvalbumin Neurons and Perineuronal Nets in the Dorsolateral Prefrontal Cortex of Subjects with Schizophrenia. Neuropsychopharmacology (2016) 0.89
Phenotypically distinct subtypes of psychosis accompany novel or rare variants in four different signaling genes. EBioMedicine (2016) 0.83
Altered fucosyltransferase expression in the superior temporal gyrus of elderly patients with schizophrenia. Schizophr Res (2016) 0.81
In Sickness and in Health: Perineuronal Nets and Synaptic Plasticity in Psychiatric Disorders. Neural Plast (2015) 0.79
MicroRNA-derived network analysis of differentially methylated genes in schizophrenia, implicating GABA receptor B1 [GABBR1] and protein kinase B [AKT1]. Biol Direct (2015) 0.79
Weaving a Net of Neurobiological Mechanisms in Schizophrenia and Unraveling the Underlying Pathophysiology. Biol Psychiatry (2016) 0.78
Exploring the genetic underpinnings of brain and behavioral disorders. J Neurogenet (2014) 0.77
Differentiation of oligodendrocyte precursors is impaired in the prefrontal cortex in schizophrenia. Schizophr Res (2015) 0.76
The schizophrenia risk gene MIR137 acts as a hippocampal gene network node orchestrating the expression of genes relevant to nervous system development and function. Prog Neuropsychopharmacol Biol Psychiatry (2016) 0.76
MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons. Mol Neurobiol (2014) 0.76
Limited predictability of postmortem human brain tissue quality by RNA integrity numbers. J Neurochem (2016) 0.76
Increased extracellular clusterin in the prefrontal cortex in schizophrenia. Schizophr Res (2015) 0.75
Diagnostic and therapeutic potential of microRNAs in neuropsychiatric disorders: Past, present, and future. Prog Neuropsychopharmacol Biol Psychiatry (2016) 0.75
Extracellular matrix proteomics in schizophrenia and Alzheimer's disease. Anal Bioanal Chem (2016) 0.75
Expression quantitative trait loci (eQTLs) in microRNA genes are enriched for schizophrenia and bipolar disorder association signals. Psychol Med (2015) 0.75
Clozapine as a Model for Antipsychotic Development. Neurotherapeutics (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res (2000) 117.00
From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res (2006) 44.35
A mammalian microRNA expression atlas based on small RNA library sequencing. Cell (2007) 34.03
KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res (2009) 28.60
Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res (2002) 28.38
Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell (2003) 25.94
Neuronal oscillations in cortical networks. Science (2004) 19.57
Integrin signaling. Science (1999) 16.44
Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA (2005) 14.14
Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci (2005) 11.68
Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun (2004) 10.03
Identification of many microRNAs that copurify with polyribosomes in mammalian neurons. Proc Natl Acad Sci U S A (2003) 7.95
Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry (2000) 6.91
Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet (2008) 6.71
Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci (2010) 5.70
Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry (1995) 5.59
The logic of TGFbeta signaling. FEBS Lett (2006) 5.26
Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci (2003) 4.86
NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci (2007) 4.35
A high-density probe array sample preparation method using 10- to 100-fold fewer cells. Nat Biotechnol (1999) 4.29
The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry (1999) 4.26
Focal adhesion regulation of cell behavior. Biochim Biophys Acta (2004) 3.83
Gamma frequency-range abnormalities to auditory stimulation in schizophrenia. Arch Gen Psychiatry (1999) 3.74
Microarray validation: factors influencing correlation between oligonucleotide microarrays and real-time PCR. Biol Proced Online (2006) 3.70
Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry (2011) 3.33
Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia. Proc Natl Acad Sci U S A (2006) 3.33
Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry (1998) 3.26
microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol (2007) 3.26
Neural synchrony indexes disordered perception and cognition in schizophrenia. Proc Natl Acad Sci U S A (2004) 2.94
MRI anatomy of schizophrenia. Biol Psychiatry (1999) 2.79
Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars. Proc Natl Acad Sci U S A (2007) 2.72
A genetic analysis of neural progenitor differentiation. Neuron (2001) 2.66
The local transcriptome in the synaptic neuropil revealed by deep sequencing and high-resolution imaging. Neuron (2012) 2.53
Neuroplasticity of neocortical circuits in schizophrenia. Neuropsychopharmacology (2007) 2.51
How the Smads regulate transcription. Int J Biochem Cell Biol (2007) 2.46
Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum Mol Genet (2008) 2.33
Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation. Crit Rev Clin Lab Sci (2004) 2.11
Neurocan is upregulated in injured brain and in cytokine-treated astrocytes. J Neurosci (2000) 1.95
A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons. J Neurosci (2006) 1.93
Reduced dendritic spine density in auditory cortex of subjects with schizophrenia. Neuropsychopharmacology (2008) 1.93
Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology. Brain (2008) 1.92
Expression profiling of ductal carcinoma in situ by laser capture microdissection and high-density oligonucleotide arrays. Am J Pathol (2001) 1.88
Reduced dorsal and orbital prefrontal gray matter volumes in schizophrenia. Arch Gen Psychiatry (2000) 1.86
Brain-derived neurotrophic factor overexpression induces precocious critical period in mouse visual cortex. J Neurosci (1999) 1.82
The p53 family and programmed cell death. Oncogene (2008) 1.81
Common variants conferring risk of schizophrenia: a pathway analysis of GWAS data. Schizophr Res (2010) 1.79
Integrins control dendritic spine plasticity in hippocampal neurons through NMDA receptor and Ca2+/calmodulin-dependent protein kinase II-mediated actin reorganization. J Neurosci (2006) 1.77
Activation of LIMK1 by binding to the BMP receptor, BMPRII, regulates BMP-dependent dendritogenesis. EMBO J (2004) 1.70
Chondroitin sulphate proteoglycans in the CNS injury response. Prog Brain Res (2002) 1.70
Cognition in schizophrenia: impairments, determinants, and functional importance. Psychiatr Clin North Am (2005) 1.63
Working memory and prefrontal cortex dysfunction: specificity to schizophrenia compared with major depression. Biol Psychiatry (2003) 1.59
Upregulation of dicer and microRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia. Biol Psychiatry (2010) 1.58
Reduced pyramidal cell somal volume in auditory association cortex of subjects with schizophrenia. Neuropsychopharmacology (2002) 1.55
Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder. Biol Psychiatry (2011) 1.49
Dynamic Network Connectivity: A new form of neuroplasticity. Trends Cogn Sci (2010) 1.48
Measurable impact of RNA quality on gene expression results from quantitative PCR. Nucleic Acids Res (2011) 1.45
Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability. Neurobiol Dis (2001) 1.44
Pyramidal cell size reduction in schizophrenia: evidence for involvement of auditory feedforward circuits. Biol Psychiatry (2004) 1.43
Growth factor and cytokine regulation of chondroitin sulfate proteoglycans by astrocytes. Glia (2005) 1.40
SUMO-1 and p53. Cell Cycle (2002) 1.34
Apoptotic mechanisms and the synaptic pathology of schizophrenia. Schizophr Res (2005) 1.30
Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells. J Neurosci (2002) 1.29
The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. Mol Psychiatry (2006) 1.28
Extracellular matrix-glial abnormalities in the amygdala and entorhinal cortex of subjects diagnosed with schizophrenia. Arch Gen Psychiatry (2010) 1.27
Regulation of neuronal Bcl2 protein expression and calcium homeostasis by transforming growth factor type beta confers wide-ranging protection on rat hippocampal neurons. Proc Natl Acad Sci U S A (1994) 1.24
Neuroregenerative effects of BMP7 after stroke in rats. J Neurol Sci (2005) 1.22
Cortical and subcortical gray matter abnormalities in schizophrenia determined through structural magnetic resonance imaging with optimized volumetric voxel-based morphometry. Am J Psychiatry (2002) 1.20
Gray matter-changes and correlates of disease severity in schizophrenia: a statistical parametric mapping study. Neuroimage (2001) 1.19
Extracellular matrix components associated with remodeling processes in brain. Cell Mol Life Sci (2004) 1.19
MRI assessment of gray and white matter distribution in Brodmann's areas of the cortex in patients with schizophrenia with good and poor outcomes. Am J Psychiatry (2003) 1.19
Developmental pattern of perineuronal nets in the human prefrontal cortex and their deficit in schizophrenia. Biol Psychiatry (2013) 1.18
Transforming growth factor-beta: a neuroprotective factor in cerebral ischemia. Cell Biochem Biophys (2003) 1.18
Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia. BMC Psychiatry (2009) 1.17
Microtubule stabilization by bone morphogenetic protein receptor-mediated scaffolding of c-Jun N-terminal kinase promotes dendrite formation. Mol Cell Biol (2010) 1.10
Dynamic control of TGF-beta signaling and its links to the cytoskeleton. FEBS Lett (2008) 1.10
Survival signaling goes BAD. Dev Cell (2002) 1.09
Comparison of RNA amplification methods and chip platforms for microarray analysis of samples processed by laser capture microdissection. J Cell Biochem (2008) 1.08
Regulation of the postsynaptic cytoskeleton: roles in development, plasticity, and disorders. J Neurosci (2010) 1.08
Transforming growth factor-beta signalling in brain disorders. Cytokine Growth Factor Rev (2005) 1.07
Localized volume reduction in prefrontal, temporolimbic, and paralimbic regions in schizophrenia: an MRI parcellation study. Psychiatry Res (2004) 1.06
Gene expression profiling in schizophrenia and related mental disorders. Neuroscientist (2006) 1.05
Circuitry-based gene expression profiles in GABA cells of the trisynaptic pathway in schizophrenics versus bipolars. Proc Natl Acad Sci U S A (2008) 1.00
Deconstructing the perineuronal net: cellular contributions and molecular composition of the neuronal extracellular matrix. Neuroscience (2012) 0.99
Gender-specific reduction of estrogen-sensitive small RNA, miR-30b, in subjects with schizophrenia. Schizophr Bull (2010) 0.98
Cerebellar deficits and hyperactivity in mice lacking Smad4. J Biol Chem (2003) 0.97
Reduced gray matter volume in schizophrenia. Arch Gen Psychiatry (1999) 0.97
Gray-matter abnormalities in deficit schizophrenia. Schizophr Res (2010) 0.96
Bone morphogenetic protein-5 (BMP-5) promotes dendritic growth in cultured sympathetic neurons. BMC Neurosci (2001) 0.95
The early differentiation of the neocortex: a hypothesis on neocortical evolution. Cereb Cortex (2001) 0.95
Reduced gray matter volume of Brodmann's Area 45 is associated with severe psychotic symptoms in patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci (2009) 0.92
Osteogenic protein-1 and related bone morphogenetic proteins regulate dendritic growth and the expression of microtubule-associated protein-2 in rat sympathetic neurons. Neurosci Lett (1998) 0.91
The crosstalk of hyaluronan-based extracellular matrix and synapses. Neuron Glia Biol (2008) 0.90
Hypoxia-ischemia induces transforming growth factor beta 1 mRNA in the infant rat brain. Brain Res Mol Brain Res (1992) 0.90
Neuronal type-specific gene expression profiling and laser-capture microdissection. Methods Mol Biol (2011) 0.89
OP-1 enhances dendritic growth from cerebral cortical neurons in vitro. Exp Neurol (1999) 0.88
Association study in the 5q31-32 linkage region for schizophrenia using pooled DNA genotyping. BMC Psychiatry (2008) 0.88
Regulation of cell cycle and DNA repair in post-mitotic GABA neurons in psychotic disorders. Neuropharmacology (2010) 0.87
Bone morphogenetic protein-7 stimulates initial dendritic growth in sympathetic neurons through an intracellular fibroblast growth factor signaling pathway. J Neurochem (2002) 0.87
Elastic fiber assembly is disrupted by excessive accumulation of chondroitin sulfate in the human dermal fibrotic disease, keloid. Biochem Biophys Res Commun (2009) 0.87
Automatically parcellating the human cerebral cortex. Cereb Cortex (2004) 18.32
Assessing the impact of population stratification on genetic association studies. Nat Genet (2004) 16.28
Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry (2008) 9.54
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry (2008) 9.00
Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells (2005) 6.72
Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia. Proc Natl Acad Sci U S A (2009) 6.09
Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma. Nat Neurosci (2002) 5.45
Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling. Cell (2009) 5.34
A review of diffusion tensor imaging studies in schizophrenia. J Psychiatr Res (2005) 4.34
The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry (2013) 4.16
Framework for the Statistical Shape Analysis of Brain Structures using SPHARM-PDM. Insight J (2006) 4.03
The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. Am J Psychiatry (2008) 4.02
At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry (2011) 3.66
Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study. Am J Psychiatry (2008) 3.29
North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull (2007) 3.28
Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology (2009) 3.27
Premorbid IQ in schizophrenia: a meta-analytic review. Am J Psychiatry (2008) 3.27
Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder. Biol Psychiatry (2006) 3.17
Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions. Biol Psychiatry (2005) 3.08
Control of sleep and wakefulness. Physiol Rev (2012) 3.06
Abnormal neural synchrony in schizophrenia. J Neurosci (2003) 3.05
Neural synchrony indexes disordered perception and cognition in schizophrenia. Proc Natl Acad Sci U S A (2004) 2.94
Early life programming and neurodevelopmental disorders. Biol Psychiatry (2010) 2.93
Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry (2007) 2.91
Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull (2009) 2.90
Uncinate fasciculus findings in schizophrenia: a magnetic resonance diffusion tensor imaging study. Am J Psychiatry (2002) 2.84
Adenosine and sleep-wake regulation. Prog Neurobiol (2004) 2.84
Cingulate fasciculus integrity disruption in schizophrenia: a magnetic resonance diffusion tensor imaging study. Biol Psychiatry (2003) 2.78
The Consortium on the Genetics of Schizophrenia: neurocognitive endophenotypes. Schizophr Bull (2006) 2.53
Cortical thinning of the attention and executive function networks in adults with attention-deficit/hyperactivity disorder. Cereb Cortex (2006) 2.44
Spatial normalization of diffusion tensor MRI using multiple channels. Neuroimage (2003) 2.39
Evidence for acquired pregenual anterior cingulate gray matter loss from a twin study of combat-related posttraumatic stress disorder. Biol Psychiatry (2007) 2.36
Impact of executive function deficits and attention-deficit/hyperactivity disorder (ADHD) on academic outcomes in children. J Consult Clin Psychol (2004) 2.30
Hierarchical genetic organization of human cortical surface area. Science (2012) 2.28
Hormonal cycle modulates arousal circuitry in women using functional magnetic resonance imaging. J Neurosci (2005) 2.25
Image-driven population analysis through mixture modeling. IEEE Trans Med Imaging (2009) 2.23
Structural brain magnetic resonance imaging of limbic and thalamic volumes in pediatric bipolar disorder. Am J Psychiatry (2005) 2.18
Chronic traumatic encephalopathy: neurodegeneration following repetitive concussive and subconcussive brain trauma. Brain Imaging Behav (2012) 2.16
Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. Arch Gen Psychiatry (2007) 2.13
White matter hemisphere asymmetries in healthy subjects and in schizophrenia: a diffusion tensor MRI study. Neuroimage (2004) 2.09
Clustering Fiber Traces Using Normalized Cuts. Med Image Comput Comput Assist Interv (2004) 2.06
A hierarchical algorithm for MR brain image parcellation. IEEE Trans Med Imaging (2007) 2.05
Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions. Schizophr Bull (2003) 2.04
A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. Biol Psychiatry (2010) 1.99
Sensory-evoked gamma oscillations in chronic schizophrenia. Biol Psychiatry (2008) 1.98
Sex differences in schizophrenia. Int Rev Psychiatry (2010) 1.96
Progressive decrease of left Heschl gyrus and planum temporale gray matter volume in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry (2003) 1.94
Genetic and environmental influences on the size of specific brain regions in midlife: the VETSA MRI study. Neuroimage (2009) 1.94
Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2011) 1.93
High-resolution line scan diffusion tensor MR imaging of white matter fiber tract anatomy. AJNR Am J Neuroradiol (2002) 1.93
Detection and analysis of statistical differences in anatomical shape. Med Image Anal (2005) 1.91
Sleep and brain energy levels: ATP changes during sleep. J Neurosci (2010) 1.88
The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophr Bull (2006) 1.88
Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study. Biol Psychiatry (2013) 1.87
Using the logarithm of odds to define a vector space on probabilistic atlases. Med Image Anal (2007) 1.86
Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia. Am J Psychiatry (2011) 1.86
A prospective longitudinal volumetric MRI study of superior temporal gyrus gray matter and amygdala-hippocampal complex in chronic schizophrenia. Schizophr Res (2009) 1.82
Functional MRI in attention-deficit hyperactivity disorder: evidence for hypofrontality. Brain Dev (2005) 1.81
Logarithm odds maps for shape representation. Med Image Comput Comput Assist Interv (2006) 1.79
North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment. Schizophr Res (2012) 1.79
Amygdala-hippocampal shape differences in schizophrenia: the application of 3D shape models to volumetric MR data. Psychiatry Res (2002) 1.78
Age-related decline in white matter tract integrity and cognitive performance: a DTI tractography and structural equation modeling study. Neurobiol Aging (2010) 1.77
Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia. Am J Psychiatry (2003) 1.75
The retrospective measurement of prenatal and perinatal events: accuracy of maternal recall. Schizophr Res (2004) 1.75
Gamma-band auditory steady-state responses are impaired in first episode psychosis. Biol Psychiatry (2008) 1.75
Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons. Eur J Neurosci (2002) 1.75
Effects of dietary glycemic index on brain regions related to reward and craving in men. Am J Clin Nutr (2013) 1.73
MRI study of caudate nucleus volume and its cognitive correlates in neuroleptic-naive patients with schizotypal personality disorder. Am J Psychiatry (2002) 1.72
Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms. Neuropsychol Rev (2003) 1.71
Global medical shape analysis using the Laplace-Beltrami spectrum. Med Image Comput Comput Assist Interv (2007) 1.71
Neurocognition in the psychosis risk syndrome: a quantitative and qualitative review. Curr Pharm Des (2012) 1.71
Increased diffusivity in superior temporal gyrus in patients with schizophrenia: a Diffusion Tensor Imaging study. Schizophr Res (2009) 1.70
Hippocampal synaptic plasticity and spatial learning are impaired in a rat model of sleep fragmentation. Eur J Neurosci (2006) 1.70
Excessive extracellular volume reveals a neurodegenerative pattern in schizophrenia onset. J Neurosci (2012) 1.69
Fear conditioning and extinction: influence of sex and menstrual cycle in healthy humans. Behav Neurosci (2006) 1.68
Analysis of different promoter systems for efficient transgene expression in mouse embryonic stem cell lines. Stem Cells (2002) 1.67
Shape of caudate nucleus and its cognitive correlates in neuroleptic-naive schizotypal personality disorder. Biol Psychiatry (2004) 1.66